Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Systems-Based Diabetes Prevention and Control Programs (DPCPS)
Interaction and Activation of the LH Receptor
MBRS Program-University of Southern Colorado
Retinal Cell Model for Batten Disease
Taking Be Proud! Be Responsible! to the Suburbs
Recently added grants:
Genetic analysis of islet-infiltrating IL-21-expressing CD4 T cells in type 1 diabetes
Prometheus: A Platform for Rapid Development of Human Antibody-based Therapeutics and Prophylactics against Emerging Viral Threats
Core A: Administrative Core
Overcoming Pyrazinamide Resistance with Pyrazinoate-Cephalosporin Conjugates
Core B: Industrialization Core
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB67184-3-0-1
Application #
7574882
Study Section
Project Start
2006-09-30
Project End
2009-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/ Children's Hosp Pittsburgh/Upmc Health Sys
$182,089
NIH 2007
N01 HL
Sildenafil for Sickle Cell Disease-Associated Pulmonary Hypertension
Lakshmanan, Krishnamurti /
$236,644
NIH 2007
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/
Comments
Be the first to comment on this grant